Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.
about
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapyPopulation pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsPharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz.Safety of lopinavir/ritonavir for the treatment of HIV-infection.Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.Lack of effect of efavirenz on the pharmacokinetics of tipranavir-ritonavir in healthy volunteers.Factors influencing lopinavir and atazanavir plasma concentration.Safety of pharmacoenhancers for HIV therapy.Induction of cytochrome P450 enzymes: a view on human in vivo findings.Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection.
P2860
Q26771182-413C2CFE-FE33-4743-9B8D-C7EC13723874Q35826931-1D0F4822-11DC-4012-B2FD-F5FB7F4C6762Q35827093-310B21E9-A0F7-4DDE-8542-B1B883238334Q36150530-8D0556C3-C2D3-49C0-8B77-135C2DF77023Q36544977-CA480007-59AA-460A-B7D2-65D0CF206FDCQ37409968-F61D425D-073E-4E5C-B320-39BF3CD58860Q37476403-AF4753ED-C7DF-4E1D-ADC7-AA7431944604Q38057371-7EF49A30-8D10-4982-A0E2-BDD1E74B6FEDQ38057372-84E02CE9-57F7-4990-90BE-A6AC0F14D971Q39033125-A42F89FB-C1AF-4F68-85FD-378D230E6418Q45226018-C2E8CFA1-7E3C-41FC-9482-08DA01FA62DFQ48164420-7BA95D5E-5B08-49F7-B496-576B5A6F8874
P2860
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@ast
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@en
type
label
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@ast
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@en
prefLabel
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@ast
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@en
P2093
P2860
P1476
Therapeutic drug monitoring of ...... verse transcriptase inhibitor.
@en
P2093
Alain Durand
Alain Lafeuillade
Bruno Lacarelle
Caroline Solas
Catherine Dhiver
Gérard Lepeu
Isabelle Ravaux
Jacques Moreau
Malika Mokhtari
Marie-Pierre Drogoul
P2860
P304
P356
10.1046/J.1365-2125.2003.02020.X
P407
P577
2004-04-01T00:00:00Z